John Paulson’s Intra-Cellular Therapies ITCI Stock Holding History
Bought
Maintained
Sold
Other funds holding ITCI
John Paulson's ITCI Position: Q2 2025 in Review
John Paulson sold out of Intra-Cellular Therapies (ITCI) in Q2 2025, closing a stake of 21,500 shares — an estimated $2.84M sold.
John Paulson first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $2.84M in Q1 2025. 3 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.
- John Paulson reported no remaining Intra-Cellular Therapies position as of Q2 2025 after selling out during the quarter.
- John Paulson sold 21,500 Intra-Cellular Therapies shares in Q2 2025, an estimated $2.84M.
- John Paulson first reported a position in Intra-Cellular Therapies in Q1 2025 and held it in 1 quarter.
- John Paulson's Intra-Cellular Therapies position peaked at $2.84M in Q1 2025.
- 3 funds tracked by Wall St. Rank held Intra-Cellular Therapies as of Q2 2025.
Based on Paulson & Co's 13F filing for Q2 2025, filed 14 Aug 2025.